Jamie L. Miller, Pharm.D., BCPS, BCPPS, FPPAG

Prof

Pharmacy Clinical & Admin Sci

Phone (405) 271-6878 x47296

Office COP300

Email jamie-miller@ou.edu


Publications & Presentations

    121. Johnson P N, Harrison D, Castro C H, Miller J L. A pilot study assessing the frequency and complexity of methadone tapers for opioid abstinence syndrome in children discharged to home. Research in social & administrative pharmacy : RSAP. 2012; 8 : 455-63

    122. Bulkley C F, Johnson P N, Henry E, Harrison D, Lewis T V, Miller J L. Bumetanide continuous-infusion dosing in critically ill pediatric patients. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2012; 69 : 1458, 1460-1

    123. Johnson P N, Miller J L, Harrison D. Evaluation of initial methadone dosing for prevention of iatrogenic opioid abstinence syndrome in children. Journal of Pediatric Intensive Care. 2012; 2 : 105-113

    124. Johnson P N, Boyles K A, Miller J L. Selection of the initial methadone regimen for the management of iatrogenic opioid abstinence syndrome in critically ill children. Pharmacotherapy. 2012; 32 : 148-57

    125. Miller J L, Nandyal R R, Anderson M, Escobedo M B. Relationship of caffeine dosing with serum alkaline phosphatase levels in extremely low-birth-weight infants. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2012; 17 : 58-66




Grants

1 2 >>
    1. Selenium Pharmacokinetics and Pharmacodynamics of Infants with Intestinal Failure a Prospective Cohort Study. Misc Non-Federal. Start Date: 2025. End Date: 2026.

    2. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.

    3. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.

    4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

    5. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

1 2 >>



Awards and Honors

<< 1 2 3 4 5 >>
                                                                                            11. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2019.  

                                                                                            12. Rho Chi, Gamma Chapter. 2019 Chapter Alumni Award. Date: 2019.  

                                                                                            13. Oklahoma Society of Health-System Pharmacists. Oklahoma Pharmacist of the Year. Date: 2019.  

                                                                                            14. University of Oklahoma College of Pharmacy; Department of Clinical and Administrative Sciences. Best Paper Award. Date: 2018.  

                                                                                            15. Pediatric Pharmacy Association. Fellow of Pediatric Pharmacy Association. Date: 2018.  

<< 1 2 3 4 5 >>



Education

                                                                                            1.  Degree: PharmD. Southwestern Oklahoma State University. Date: 2006.  

                                                                                            2.  Degree: BS. Trevecca Nazarene University. Date: 2002.  




Administrative Assignments

                                                

    1. Role: Department Vice-Chair. Scope: Department. Date: 2021.